EUVIMEDEUVIMED entdecken
Crossref

Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment

M.E. Vaccari, S. Salvi, G. Rossino, A. Malacrida, L. Molteni, M. Di Giacomo, P. Linciano, D. Rossi, M.R. Miloso, S. Collina

European Journal of Cancer · 2026-11 · 248 · 117738

DOI: 10.1016/j.ejca.2026.117738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von M.E. Vaccari und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vaccari, M., Salvi, S., Rossino, G., Malacrida, A., Molteni, L., Giacomo, M. D., Linciano, P., Rossi, D., Miloso, M., & Collina, S. (2026). Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment. European Journal of Cancer, 248, 117738. https://doi.org/10.1016/j.ejca.2026.117738

Vancouver

Vaccari M, Salvi S, Rossino G, Malacrida A, Molteni L, Giacomo MD, et al. Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment. European Journal of Cancer. 2026;248:117738. doi:10.1016/j.ejca.2026.117738

BibTeX
@article{Vaccari2026,
  author = {Vaccari, M.E. and Salvi, S. and Rossino, G. and Malacrida, A. and Molteni, L. and Giacomo, M. Di and Linciano, P. and Rossi, D. and Miloso, M.R. and Collina, S.},
  title = {Novel Multi-Target-Directed Ligands for Glioblastoma Combining Sigma Receptor Modulation and Proteasome Impairment},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117738},
  doi = {10.1016/j.ejca.2026.117738}
}
Kostenlos starten →